The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial
Authors
Ki Tae Suk (ORCID: https://orcid.org/0000-0002-9206-9245)
Ji-Sook Han (ORCID: https://orcid.org/0000-0002-6282-6815)
Sung‐Min Won (ORCID: https://orcid.org/0000-0002-5386-0544)
The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial
Ki Tae Suk, Ji-Sook Han, Sung‐Min Won, Sang Hak Han et al.
Journal
Journal of Translational Medicine
Topics
Liver Disease Diagnosis and Treatment
article
The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial
Ki Tae Suk, Ji-Sook Han, Sung‐Min Won, Sang Hak Han, Hyunchae Joung, Dong Joon Kim, I. Park, Young Lim Ham, Yoojin Kwon
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Translational MedicineVol. 24(1)
Institutions
Hallym University (KR), Chong Kun Dang Bio (South Korea) (KR), Daewon University College (KR)